Russia can bring pharma innovations to market with AI, support - SPIEF
L'essentiel
- Participants at SPIEF-2026 believe Russia can succeed in the global pharmaceutical market by integrating AI, modern tech platforms, and regulatory/financial support.
- A key challenge identified is creating guaranteed demand for new drugs to attract investment.
Résumé généré par IA
Pourquoi c'est important
Participants at the St. Petersburg International Economic Forum (SPIEF-2026) discussed Russia's potential to compete in the global pharmaceutical market. Key elements for success include combining AI, modern technological platforms, targeted regulatory and financial support, and creating guaranteed demand for new drugs.
ST. PETERSBURG, June 3. /TASS/. Russia will be able to bring domestic pharmaceutical innovations to the world market if it combines artificial intelligence, modern technological platforms, targeted regulatory and financial support, and creates guaranteed demand for new drugs, participants in the St. Petersburg International Economic Forum (SPIEF) said.
"Pharmaceutical innovations are impossible today without modern technological platforms and the widespread use of artificial intelligence," said Katerina Tikhonova, the CEO of Innopraktika company.
Elena Popova, the Deputy General Director of the Russian Science Foundation noted that the Russian Science Foundation supports research throughout the almost entire research and process cycle of product development. Every year, the foundation supports more than 8,000 projects involving more than 800 organizations and more than 55,000 researchers.
Sergey Glagolev, the Russian Deputy Minister of Health, noted that the Russian regulatory system and the competencies of the pharmaceutical industry already make it possible to produce and localize platform solutions for innovative drugs.
Guaranteed demand remains a key problem for the industry, the official said. Government approaches should create incentives and alternative mechanisms where such demand cannot be met directly, he stressed. This is necessary for investments in innovative developments to become attractive, Glagolev added.
The 29th St. Petersburg International Economic Forum (SPIEF-2026) is taking place on June 3-6. The forum program is dedicated to shaping a new model of global development amid the ongoing transformation of the world economy. The Roscongress Foundation is the organizer of the St. Petersburg International Economic Forum. TASS is its official general information partner.
À surveiller
Perspective IA — des possibilités, pas des certitudes
Russia will successfully bring domestic pharmaceutical innovations to the world market.
Possible · Long terme
Questions ouvertes
- What specific regulatory and financial support mechanisms will be implemented?
- How will guaranteed demand for new drugs be created or incentivized?
- What are the timelines for these innovations to reach the world market?
- Which specific technological platforms will be prioritized?
